Association of Glycated Hemoglobin (HbA1c) with Functional Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke
Clinical Interventions in Aging · 2026
DOI: 10.2147/cia.s569850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Interventions in Aging, 2026. Verfasst von Huaishun Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Thrombectomy, Ischemic Stroke, Endovascular Procedures. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
The impact of chronic glycemic control, measured by glycated hemoglobin (HbA1c), on functional outcomes after endovascular thrombectomy (EVT) for acute large vessel occlusion (LVO) stroke remains to be fully elucidated.
Methods
We conducted a retrospective cohort study of 443 consecutive patients with anterior circulation LVO stroke who underwent EVT. Patients were categorized by HbA1c levels: low ( 7.0%). The primary outcome was a poor functional outcome (modified Rankin Scale score 3-6) at 3 months. The secondary outcome was symptomatic intracranial hemorrhage (sICH).
Results
Among the 443 patients, 229 (51.7%) had a poor functional outcome. Higher HbA1c levels were significantly associated with an increased risk of poor outcome after adjustment for confounders (P for trend = 0.013). When analyzed as a continuous variable, HbA1c showed a nonlinear relationship with poor outcome; risk increased with rising HbA1c until a threshold of 7.1%, after which the rate of increase attenuated. No significant association was found between HbA1c and sICH. Subgroup analysis revealed a significant interaction between HbA1c and thrombolysis (t-PA) administration (P for interaction = 0.042), indicating that the association between high HbA1c and poor outcome was more pronounced in patients who received t-PA.
Conclusion
Elevated HbA1c is independently associated with an increased risk of poor 3-month functional outcomes after EVT, with a risk threshold observed at 7.1%. These findings underscore the importance of long-term glycemic control in stroke management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
- Fourth Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
Zitieren
APA
Wang, H., Tao, D., Du, J., Chen, J., & Xiao, G. (2026). Association of Glycated Hemoglobin (HbA1c) with Functional Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s569850
Vancouver
Wang H, Tao D, Du J, Chen J, Xiao G. Association of Glycated Hemoglobin (HbA1c) with Functional Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke. Clinical Interventions in Aging. 2026. doi:10.2147/cia.s569850
BibTeX
@article{Wang2026,
author = {Wang, Huaishun and Tao, Dan and Du, Junhao and Chen, Jie and Xiao, Guodong},
title = {Association of Glycated Hemoglobin (HbA1c) with Functional Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke},
journal = {Clinical Interventions in Aging},
year = {2026},
doi = {10.2147/cia.s569850}
}
EUVIMED